GALVANIN, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 2.395
AS - Asia 981
EU - Europa 667
AF - Africa 226
SA - Sud America 215
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.515
Nazione #
US - Stati Uniti d'America 2.280
SG - Singapore 358
CN - Cina 200
BR - Brasile 131
VN - Vietnam 125
HK - Hong Kong 97
GB - Regno Unito 92
IT - Italia 79
FI - Finlandia 73
DE - Germania 68
NL - Olanda 52
UA - Ucraina 33
PL - Polonia 31
SE - Svezia 30
FR - Francia 26
IN - India 16
RU - Federazione Russa 15
CA - Canada 14
EC - Ecuador 13
MX - Messico 13
AR - Argentina 12
ES - Italia 12
TN - Tunisia 12
PY - Paraguay 11
SA - Arabia Saudita 11
DK - Danimarca 10
GR - Grecia 10
GT - Guatemala 10
IQ - Iraq 10
JP - Giappone 10
AT - Austria 9
CI - Costa d'Avorio 9
CO - Colombia 9
ID - Indonesia 9
KE - Kenya 9
ML - Mali 9
PK - Pakistan 9
PS - Palestinian Territory 9
SI - Slovenia 9
SK - Slovacchia (Repubblica Slovacca) 9
SO - Somalia 9
ZA - Sudafrica 9
BE - Belgio 8
CL - Cile 8
GF - Guiana Francese 8
KG - Kirghizistan 8
NC - Nuova Caledonia 8
NE - Niger 8
PE - Perù 8
RS - Serbia 8
TR - Turchia 8
UG - Uganda 8
ZW - Zimbabwe 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
CG - Congo 7
CR - Costa Rica 7
CZ - Repubblica Ceca 7
IE - Irlanda 7
ME - Montenegro 7
MZ - Mozambico 7
NG - Nigeria 7
NO - Norvegia 7
PR - Porto Rico 7
UY - Uruguay 7
UZ - Uzbekistan 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
CH - Svizzera 6
HT - Haiti 6
IR - Iran 6
JO - Giordania 6
MA - Marocco 6
MN - Mongolia 6
MU - Mauritius 6
MW - Malawi 6
MY - Malesia 6
NZ - Nuova Zelanda 6
RE - Reunion 6
VE - Venezuela 6
ZM - Zambia 6
AZ - Azerbaigian 5
BG - Bulgaria 5
BJ - Benin 5
CM - Camerun 5
CV - Capo Verde 5
CW - ???statistics.table.value.countryCode.CW??? 5
DJ - Gibuti 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EG - Egitto 5
ET - Etiopia 5
GH - Ghana 5
GP - Guadalupe 5
HR - Croazia 5
KH - Cambogia 5
LA - Repubblica Popolare Democratica del Laos 5
NP - Nepal 5
PF - Polinesia Francese 5
PT - Portogallo 5
Totale 4.326
Città #
Fairfield 278
Ashburn 215
Singapore 201
Woodbridge 187
Houston 172
Chandler 149
Ann Arbor 135
Seattle 126
Jacksonville 118
Cambridge 116
Wilmington 112
Hong Kong 92
Santa Clara 77
Dong Ket 62
Beijing 57
Boardman 52
Princeton 36
Helsinki 35
Bytom 26
Nanjing 23
San Diego 22
Los Angeles 21
Medford 21
Roxbury 21
Ho Chi Minh City 19
London 16
Des Moines 14
Hanoi 14
New York 14
São Paulo 14
Chicago 13
Council Bluffs 13
Buffalo 12
Camden 12
Munich 12
Turku 10
Abidjan 9
Milan 9
Padova 9
Bamako 8
Bishkek 8
Guatemala City 8
Hackney 8
Kampala 8
Nairobi 8
Nanchang 8
Noumea 8
Harare 7
Niamey 7
Redondo Beach 7
Amman 6
Belgrade 6
Brooklyn 6
Cagliari 6
Cayenne 6
Haiphong 6
Hebei 6
Jeddah 6
Kongens Lyngby 6
Lilongwe 6
Lusaka 6
Newark 6
Salt Lake City 6
San José 6
Tashkent 6
Toronto 6
Ulan Bator 6
Accra 5
Addis Ababa 5
Chennai 5
Cotonou 5
Dublin 5
Frankfurt am Main 5
Hargeisa 5
Johannesburg 5
Karachi 5
Kingston 5
Lima 5
Manchester 5
Phnom Penh 5
Podgorica 5
Rome 5
Tokyo 5
Vicenza 5
Vienna 5
Washington 5
Antwerp 4
Baku 4
Castries 4
Dakar 4
Denver 4
Dubai 4
Guayaquil 4
Havana 4
Hounslow 4
Jiaxing 4
Lagos 4
Managua 4
Maputo 4
Minsk 4
Totale 2.882
Nome #
Optimal model-based design of experiments in dynamic systems: novel techniques and unconventional applications 339
A Framework for Model-Based Design of Parallel Experiments in Dynamic Systems 193
Bacterial inactivation on solid food matrices through supercritical CO2: a correlative study 183
Model-based design of experiments in the presence of continuous measurement systems 182
Optimal design of clinical tests for the identification of physiological models of type 1 diabetes in the presence of model mismatch 175
A model-based approach to the automatic diagnosis of von Willebrand disease 170
A backoff strategy for model-based experiment design under parametric uncertainty. 168
Identification of physiological models of type 1 diabetes mellitus by model-based design of experiments. 167
A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models. 160
Identification of complex models of type 2 diabetes from IVGTT data by model-based design of experiments 156
On the use of continuous glucose monitoring systems to design optimal clinical tests for the identification of type 1 diabetes models 155
Parallel design of pharmacodynamic experiments for the identification of antimicrobial-resistant bacterial population models 153
Towards model-based diagnosis of von Willebrand disease 152
An identifiable state model to describe light intensity influence on microalgae growth 151
Online redesign of clinical tests for the identification of type 1 diabetes models in the presence of continuous glucose monitoring systems. 150
Online model-based redesign of experiments with erratic models: a disturbance estimation approach 149
A disturbance estimation approach for online model-based redesign of experiments in the presence of systematic errors. 149
On the optimal design of clinical tests for the identification of physiological models of type 1 diabetes mellitus 140
Model-Based Design of Parallel Experiments 140
Online model-based re-design of experiments for parameter estimation in dynamic systems. 139
On the optimal design of clinical tests for the identification of type 1 diabetes models in the presence of continuous glucose monitoring systems 135
A framework for model-based design of experiments in the presence of continuous measurement systems. 129
Optimal Design of Clinical Tests for the Identification of Physiological Models of Type 1 Diabetes Mellitus 125
Towards on-line model-based design of experiments 122
An exploratory model-based design of experiments approach to aid parameters identification and reduce model prediction uncertainty 103
Modeling the effect of light intensity in microalgae growth 102
Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival 95
A backoff-based strategy to improve robustness in model-based experimental design under parametric uncertainty. 92
A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease 87
Towards the optimal design of a minimal set of clinical tests for the identification and characterization of von Willebrand disease 85
Progettazione ottimale di test clinici per l'identificazione di modelli fisiologici del diabete mellito di tipo 1 75
Totale 4.521
Categoria #
all - tutte 13.656
article - articoli 6.913
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.845
Totale 24.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 28 7 31 38 24 33 79
2021/2022396 18 51 63 20 12 14 21 42 18 17 47 73
2022/2023330 49 25 23 29 59 40 0 30 51 1 13 10
2023/2024248 30 35 30 13 27 14 10 13 12 4 29 31
2024/2025783 14 55 24 40 148 15 29 60 52 31 127 188
2025/20261.430 147 212 363 408 293 7 0 0 0 0 0 0
Totale 4.521